Estimations des analystes de Wall Street pour Cibus, Inc. (CBUS): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.20 | ||
| 2026-08-13 | $-0.29 | $-0.19 | -52.6% |
| 2026-05-14 | $-0.33 | $-0.35 | +5.7% |
| 2026-03-17 | $-0.42 | $-0.43 | +2.3% |
| 2025-11-13 | $-0.44 | $-0.41 | -7.3% |
| 2025-08-14 | $-0.61 | $-0.69 | +11.6% |
| 2025-05-08 | $-1.34 | $-0.70 | -91.4% |
| 2025-03-20 | $-0.87 | $-0.68 | -27.9% |
Ratios de valorisation
| Prix / Valeur comptable | 8.09 |
| EV / EBITDA | -2.29 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $399000 | $508000 | $236000 | $7.3M | $23.9M | $26.0M | $157000 | $1.8M | $4.3M | $3.6M |
| Coût des Ventes | $200000 | $551000 | $1.1M | $9.3M | $35.1M | $28.6M | $1.5M | $395000 | $6.9M | $5.9M |
| Marge Brute | $199000 | -$43000 | -$845000 | -$2.0M | -$11.3M | -$2.6M | -$1.4M | $1.4M | -$2.6M | -$2.3M |
| R&D | $5.6M | $11.6M | $9.8M | $12.2M | $11.1M | $11.3M | $11.6M | $42.4M | $50.4M | $44.2M |
| Frais Généraux | $6.7M | $14.7M | $18.5M | $24.1M | $20.8M | $15.4M | $9.4M | $28.9M | $30.8M | $26.9M |
| Charges Opérationnelles | $12.3M | $25.7M | $27.3M | $37.7M | $32.6M | $26.8M | $21.0M | $320.3M | $74.4M | $65.2M |
| Résultat Opérationnel | -$12.1M | -$25.8M | -$28.1M | -$39.7M | -$43.8M | -$29.3M | -$22.4M | -$318.9M | -$77.0M | -$67.5M |
| EBITDA | -$11.7M | -$25.2M | -$25.6M | -$36.5M | -$41.5M | -$25.4M | -$15.2M | -$314.6M | -$241.6M | -$90.8M |
| Charges d'Intérêt | $5000 | $1000 | $1.3M | $1.5M | $1.4M | $1.4M | $87000 | $18.9M | $34.2M | $35.5M |
| Résultat Avant Impôts | -$12.1M | -$26.0M | -$27.9M | -$39.6M | -$44.8M | -$29.2M | -$16.9M | -$337.6M | -$282.7M | -$132.2M |
| Impôts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$4000 | $29000 | $29000 |
| Résultat Net | -$12.1M | -$26.0M | -$27.9M | -$39.6M | -$44.8M | -$29.2M | -$16.9M | -$267.6M | -$251.4M | -$127.1M |
| BPA | $-21.86 | $-46.86 | $-45.46 | $-60.37 | $-66.16 | $-38.96 | $-18.36 | $-25.95 | $-10.83 | $-2.78 |
| BPA Dilué | $-21.86 | $-46.86 | $-45.46 | $-60.37 | $-66.16 | $-38.96 | $-18.36 | $-25.95 | $-10.83 | $-2.78 |
| Actions en Circulation (Diluées) | $553000 | $554375 | $613668 | $656113 | $677648 | $749515 | $919950 | $10.3M | $23.2M | $45.8M |
Prix
| Prix | $1.51 |
| Capitalisation | $115M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ACRV · BMEA · CAMP · IMUX · MNOV · PMVP · RLMD
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CBUS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions